Psoriatic Arthritis
Conference Coverage
Birth outcomes unaffected by paternal immunosuppressive therapy
VIENNA - Paternal use of systemic immunosuppressive agents in the months prior to conception didn't result in increased risk of preterm birth,...
From the Journals
Psoriasis not consistently linked to adverse pregnancy outcomes
Psoriasis was not consistently associated with adverse pregnancy outcomes across nine studies in a systematic review of the literature, but four...
News from the FDA/CDC
FDA approves biosimilar adalimumab
There are “no clinically meaningful differences” between Amgen’s biosimilar adalimumab (Amjevita) and AbbVie’s branded product Humira, the Food...
Conference Coverage
Shining a light on nonplaque psoriasis
Key clinical point: The Comprehensive Assessment of the Psoriasis Patient measure could expand the number of patients with moderate to severe...
Conference Coverage
Skin microbiome may differ in unique ways in psoriatic arthritis, psoriasis patients
Key clinical point:Changes in skin microbiome diversity in patients with psoriasis might someday help to predict progression to psoriatic...
Conference Coverage
Ultrasound’s role in detecting enthesitis in psoriatic arthritis remains debatable
Key clinical point: Ultrasound can diagnose enthesitis in psoriatic arthritis, but findings differ from physical exam. Major finding: Multivariate...
Conference Coverage
Psoriatic flare assessment tool in validation stage
MIAMI – Reaching consensus on measurement and assessment of flare in psoriatic arthritis remains challenging, especially with no widely accepted...
Conference Coverage
Psoriatic arthritis patients face more endocrine comorbidities
MIAMI – Diabetes mellitus, hypothyroidism, Cushing’s disease, and osteoporosis occur more frequently in people with psoriatic arthritis than in...
Conference Coverage
Benefits, challenges emerge in evolution of rheumatology-dermatology clinics
Conference Coverage
Psoriatic arthritis patients have elevated risk for coronary artery plaque
Key clinical point:Imaging reveals a higher rate and greater extent of coronary plaque in people with psoriatic arthritis versus healthy controls...
News
Brodalumab approval recommended, despite possible suicide signal
An FDA advisory committee has supported approval of the monoclonal antibody brodalumab for treating moderate to severe plaque psoriasis.